Genzyme Therapeutic Products Limited Partnership
US H-1B Labor Condition Application activity for Genzyme Therapeutic Products Limited Partnership. Filed 130 disclosures between FY2013 and FY2026 from worksites with a MA headquarters indicator.
H-1B outcome breakdown
Share of Genzyme Therapeutic Products Limited Partnership’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 81.5% |
| Cert-withdrawn | 16.1% |
| Withdrawn | 0.8% |
| Denied | 1.5% |
Top occupations sponsored
SOC codes filed most by Genzyme Therapeutic Products Limited Partnership across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 17-2112 | Industrial Engineers | 47 |
| 2 | 15-1253 | Software Quality Assurance Analysts and Testers | 23 |
| 3 | 13-1041 | Compliance Officers | 11 |
| 4 | 17-2041 | Chemical Engineers | 10 |
| 5 | 15-2041 | Statisticians | 5 |
| 6 | 11-3051 | Industrial Production Managers | 4 |
| 7 | 15-1252 | Software Developers | 3 |
| 8 | 15-2051 | Data Scientists | 3 |
| 9 | 11-9041 | Architectural and Engineering Managers | 3 |
| 10 | 17-2141 | Mechanical Engineers | 3 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2013 | 12 |
| FY2014 | 35 |
| FY2015 | 16 |
| FY2016 | 12 |
| FY2017 | 24 |
| FY2018 | 6 |
| FY2019 | 8 |
| FY2020 | 1 |
| FY2021 | 2 |
| FY2024 | 3 |
| FY2025 | 6 |
| FY2026 | 5 |
| Period | Value |
|---|---|
| FY2013 | 12 |
| FY2014 | 35 |
| FY2015 | 16 |
| FY2016 | 12 |
| FY2017 | 24 |
| FY2018 | 6 |
| FY2019 | 8 |
| FY2020 | 1 |
| FY2021 | 2 |
| FY2024 | 3 |
| FY2025 | 6 |
| FY2026 | 5 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.